vs

Side-by-side financial comparison of Accelerant Holdings (ARX) and U S PHYSICAL THERAPY INC (USPH). Click either name above to swap in a different company.

Accelerant Holdings is the larger business by last-quarter revenue ($267.4M vs $202.7M, roughly 1.3× U S PHYSICAL THERAPY INC). U S PHYSICAL THERAPY INC runs the higher net margin — 2.0% vs -511.9%, a 513.9% gap on every dollar of revenue.

Accelerant Holdings is a global specialty insurance and reinsurance technology platform that leverages advanced data analytics and risk assessment tools to support insurance carriers, managing general agents, and underwriting partners. It delivers tailored risk solutions, streamlines underwriting workflows, and serves commercial and specialty insurance segments across North America and European markets.

U.S. Physical Therapy Inc. operates hundreds of outpatient physical therapy clinics across the U.S. It offers rehabilitative care for patients recovering from injuries, surgeries, chronic pain and mobility impairments, plus specialized services including sports medicine and pediatric rehabilitation.

ARX vs USPH — Head-to-Head

Bigger by revenue
ARX
ARX
1.3× larger
ARX
$267.4M
$202.7M
USPH
Higher net margin
USPH
USPH
513.9% more per $
USPH
2.0%
-511.9%
ARX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARX
ARX
USPH
USPH
Revenue
$267.4M
$202.7M
Net Profit
$-1.4B
$4.2M
Gross Margin
19.8%
Operating Margin
-507.7%
8.3%
Net Margin
-511.9%
2.0%
Revenue YoY
12.3%
Net Profit YoY
-55.1%
EPS (diluted)
$-6.99
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARX
ARX
USPH
USPH
Q4 25
$202.7M
Q3 25
$267.4M
$197.1M
Q2 25
$219.1M
$197.3M
Q1 25
$183.8M
Q4 24
$180.4M
Q3 24
$168.0M
Q2 24
$167.2M
Q1 24
$155.7M
Net Profit
ARX
ARX
USPH
USPH
Q4 25
$4.2M
Q3 25
$-1.4B
$13.1M
Q2 25
$8.8M
$12.4M
Q1 25
$9.9M
Q4 24
$9.2M
Q3 24
$6.6M
Q2 24
$7.5M
Q1 24
$8.0M
Gross Margin
ARX
ARX
USPH
USPH
Q4 25
19.8%
Q3 25
18.7%
Q2 25
21.1%
Q1 25
16.9%
Q4 24
18.0%
Q3 24
17.3%
Q2 24
20.3%
Q1 24
18.2%
Operating Margin
ARX
ARX
USPH
USPH
Q4 25
8.3%
Q3 25
-507.7%
12.8%
Q2 25
10.2%
12.6%
Q1 25
10.7%
Q4 24
10.9%
Q3 24
7.6%
Q2 24
9.3%
Q1 24
9.6%
Net Margin
ARX
ARX
USPH
USPH
Q4 25
2.0%
Q3 25
-511.9%
6.7%
Q2 25
4.0%
6.3%
Q1 25
5.4%
Q4 24
5.1%
Q3 24
3.9%
Q2 24
4.5%
Q1 24
5.2%
EPS (diluted)
ARX
ARX
USPH
USPH
Q4 25
$-0.44
Q3 25
$-6.99
$0.48
Q2 25
$0.04
$0.58
Q1 25
$0.80
Q4 24
$0.52
Q3 24
$0.39
Q2 24
$0.47
Q1 24
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARX
ARX
USPH
USPH
Cash + ST InvestmentsLiquidity on hand
$1.6B
$35.6M
Total DebtLower is stronger
$121.9M
Stockholders' EquityBook value
$676.1M
$476.4M
Total Assets
$7.9B
$1.2B
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARX
ARX
USPH
USPH
Q4 25
$35.6M
Q3 25
$1.6B
$31.1M
Q2 25
$1.4B
$34.1M
Q1 25
$39.2M
Q4 24
$41.4M
Q3 24
$117.0M
Q2 24
$112.9M
Q1 24
$132.3M
Total Debt
ARX
ARX
USPH
USPH
Q4 25
Q3 25
$121.9M
Q2 25
$126.7M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ARX
ARX
USPH
USPH
Q4 25
$476.4M
Q3 25
$676.1M
$503.6M
Q2 25
$346.2M
$500.8M
Q1 25
$497.3M
Q4 24
$488.9M
Q3 24
$482.8M
Q2 24
$484.6M
Q1 24
$479.8M
Total Assets
ARX
ARX
USPH
USPH
Q4 25
$1.2B
Q3 25
$7.9B
$1.2B
Q2 25
$7.5B
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.0B
Q2 24
$1.0B
Q1 24
$1.0B
Debt / Equity
ARX
ARX
USPH
USPH
Q4 25
Q3 25
0.18×
Q2 25
0.37×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARX
ARX
USPH
USPH
Operating Cash FlowLast quarter
$73.9M
$24.9M
Free Cash FlowOCF − Capex
$21.0M
FCF MarginFCF / Revenue
10.4%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
6.00×
TTM Free Cash FlowTrailing 4 quarters
$61.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARX
ARX
USPH
USPH
Q4 25
$24.9M
Q3 25
$73.9M
$19.9M
Q2 25
$309.3M
$34.9M
Q1 25
$-4.7M
Q4 24
$19.4M
Q3 24
$22.1M
Q2 24
$29.0M
Q1 24
$4.4M
Free Cash Flow
ARX
ARX
USPH
USPH
Q4 25
$21.0M
Q3 25
$15.6M
Q2 25
$31.6M
Q1 25
$-7.3M
Q4 24
$16.9M
Q3 24
$19.6M
Q2 24
$26.7M
Q1 24
$2.6M
FCF Margin
ARX
ARX
USPH
USPH
Q4 25
10.4%
Q3 25
7.9%
Q2 25
16.0%
Q1 25
-3.9%
Q4 24
9.4%
Q3 24
11.7%
Q2 24
15.9%
Q1 24
1.7%
Capex Intensity
ARX
ARX
USPH
USPH
Q4 25
1.9%
Q3 25
2.2%
Q2 25
1.6%
Q1 25
1.4%
Q4 24
1.4%
Q3 24
1.5%
Q2 24
1.4%
Q1 24
1.2%
Cash Conversion
ARX
ARX
USPH
USPH
Q4 25
6.00×
Q3 25
1.52×
Q2 25
35.15×
2.81×
Q1 25
-0.47×
Q4 24
2.10×
Q3 24
3.34×
Q2 24
3.86×
Q1 24
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARX
ARX

Underwriting Segment$117.6M44%
Exchange Services Segment$85.0M32%
Other$64.8M24%

USPH
USPH

Net Patient Revenues$169.7M84%
Industrial Injury Prevention Services Revenues$28.9M14%
Management Contract Revenues$2.3M1%

Related Comparisons